BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 12375043)

  • 1. BRCA1 in non-inherited breast carcinomas (Review).
    Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.
    Wilson CA; Ramos L; VillaseƱor MR; Anders KH; Press MF; Clarke K; Karlan B; Chen JJ; Scully R; Livingston D; Zuch RH; Kanter MH; Cohen S; Calzone FJ; Slamon DJ
    Nat Genet; 1999 Feb; 21(2):236-40. PubMed ID: 9988281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
    Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
    J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
    Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
    Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the BRCA1 gene in human cancer.
    Xu CF; Solomon E
    Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
    Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
    Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of BRCA1 gene in breast cancer.
    Kachhap SK; Ghosh SN
    Indian J Exp Biol; 2001 May; 39(5):391-400. PubMed ID: 11510120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 gene in breast cancer.
    Rosen EM; Fan S; Pestell RG; Goldberg ID
    J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
    Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
    Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases.
    Hadjisavvas A; Mikellidou C; Zenios A; Zouvani I; Adamou A; Christodoulou Ch; Kyriacou K
    Ultrastruct Pathol; 2002; 26(4):237-44. PubMed ID: 12227949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
    Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic.
    Foretova L; Machackova E; Navratilova M; Pavlu H; Hruba M; Lukesova M; Valik D
    Hum Mutat; 2004 Apr; 23(4):397-8. PubMed ID: 15024741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
    van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
    Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.